Efficacy of apremilast, an oral phosphodiesterase 4 inhibitor, on physical function and pain in patients with psoriatic arthritis, including current skin involvement: Results of a phase 3, randomized, controlled trial
Services
Services
Date issued
2013Journal title
Annals of the rheumatic diseases
Type of content
Publicación de congreso
